Judging from its top line, AstraZeneca had a stellar 2024, generating an 18% increase in revenue, with 14 of the products in ...

The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million ...

AstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...

AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...

Pascal Soriot (pictured) topped up his basic salary of £1.8m with extras that included a bonus of £3.5m and share awards ...

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed earlier this week, saying Labour failed to match the previous government’s ...

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision. The boss of drugmaker AstraZeneca has said he was ‘very disappointed’ with the firm’s ...

Pascal Soriot, chief executive officer of the UK’s biggest drugmaker, was responding to reports that the company’s relationship with the new Labour government has soured, with Britain being ...

Despite the discontinuations, CEO Pascal Soriot said AstraZeneca’s December 2020 acquisition of Alexion was a “fantastic” ...

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it scrapped plans to build a 450 million pound ($558.86 million) vaccine plant ...